|
|
|
|||
| Home Help Feedback Subscriptions Archive Search Table of Contents | ||||
First published online 11 July 2007
doi: 10.1242/dev.001925
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||

1 Department of Physiology, Faculty of Medical and Health Sciences, University
of Auckland, Private Bag 92019, Auckland, New Zealand.
2 Section of Audiology, Faculty of Medical and Health Sciences, University of
Auckland, Private Bag 92019, Auckland, New Zealand.
Author for correspondence (e-mail:
jm.montgomery{at}auckland.ac.nz)
Accepted 7 June 2007
| SUMMARY |
|---|
|
|
|---|
Key words: Cochlea, Afferent nerve fibers, Neurite, Peripherin, ChAT, Neuronal tracer, Tetramethyl rhodamine dextran, Hearing, Mouse
| INTRODUCTION |
|---|
|
|
|---|
Before the cochlear afferent innervation reaches this mature configuration,
there is an initial mismatch, where both populations of SGN innervate both
types of sensory hair cells: during the first postnatal week in the rodent
cochlea, type I SGN innervation is eliminated from the OHC and type II SGN
innervation is eliminated from the IHC
(Perkins and Morest, 1975
;
Echteler, 1992
;
Simmons, 1994
). One major
obstacle to defining neurite retraction and synaptic remodeling in the cochlea
has been the inability to distinguish the origin of the nerve fibers either
before or during neurite retraction from the mismatched hair cells. Previous
studies have revealed the overall pattern of axonal growth in the cochlea
using electron microscopy, Golgi staining, horseradish peroxidase
histochemistry and lipophilic dyes to label SGN and trace the nerve fibers to
the hair cell region during development
(Perkins and Morest, 1975
;
Echteler, 1992
;
Simmons, 1994
;
Bruce et al., 1997
). However,
it has not been possible to unequivocally identify the SGN subtypes until
neurite reorganization was complete. For the first time, we have independently
tracked the development of the two SGN populations in the mouse cochlea using
tetramethylrhodamine-conjugated dextran (TMRD) to label type I SGN and
peripherin immunolabeling to identify type II SGN. This has enabled us to
directly visualize the time frame and the dynamics of the developing afferent
innervation patterns and precisely define the spatiotemporal reorganization of
auditory neurites that precedes the onset of hearing.
| MATERIALS AND METHODS |
|---|
|
|
|---|
Neuronal tracer application
The neuronal tracer TMRD (3000 Da MW, anionic and lysine fixable, Molecular
Probes, USA) moves along nerve processes in the antero- and retrograde
direction largely via diffusion (Gimlich
and Braun, 1985
; Glover et
al., 1986
; Popov and Poo,
1992
; Fritzsch,
1993
; Kaneko et al.,
1996
; Kobbert et al.,
2000
). TMRD is hydrophilic, enabling fast dye uptake into the
axoplasm of the cut nerve fibers, and exhibits high signal efficacy compared
with other fluorochrome-conjugated dextrans. Previous studies have shown TMRD
to provide significant resolution of nerve terminal structures and a high
specificity of labeling (Glover et al.,
1986
; Fritzsch,
1993
; Kaneko et al.,
1996
; Kobbert et al.,
2000
). Therefore TMRD was utilized to identify the innervation
patterns of nerve processes in the developing cochlea. TMRD of 3 kDa was
chosen because of its faster diffusion rate compared with larger molecular
weight dextrans. The most prominent advantage of this tracer arose from a
fortuitous observation of ours: when TMRD was applied to the freshly cut
eighth cranial (vestibulocochlear) nerve, it was transported within minutes to
the neuronal cell bodies that had neurites projecting as radial fibers solely
to the IHC. The specific labeling of neonatal type I SGN by TMRD was
substantiated by the results of this developmental study.
The medial surface of the auditory bulla and the internal auditory meatus
were exposed by sectioning the cranium in the sagittal plane and removing the
brain. TMRD crystals were manually applied with fine forceps to the
vestibulocochlear nerve bundle at the internal auditory meatus and incubated
at room temperature for 20 minutes [modified from Boyer et al.
(Boyer et al., 2004
)]. To
remove excess dye crystals, the tissue was rinsed with artificial
cerebrospinal fluid [aCSF; 130 mM NaCl, 3 mM KCl, 2 mM CaCl2, 1.3
mM NaH2PO4, 2 mM MgSO4, 20 mM glucose, 20 mM
NaHCO3, 0.4 mM ascorbic acid, pH 7.4]. Cochleae were dissected and
incubated at room temperature for 4 hours in aerated or oxygenated (carbogen
95% O2 and 5% CO2) aCSF. Temperature and incubation time
were optimized from multiple trials: the incubation time was optimized
according to the diffusion rate [2 mm/hour at 22°C for 3 kDa dextran
(Fritzsch, 1993
)], the travel
distance of TMRD in the nerve fibers from the internal auditory meatus to the
apical region through the spiral ganglion neurones to the nerve terminals
(
4 mm in P0-P6 mouse), and the time required to attain the maximum signal
at the nerve terminals through the turns without tissue degradation from
autolysis (see Fig. S1 in the supplementary material). Incubation times of
less than 4 hours resulted in a weaker signal in the nerve terminals in the
mid and apical regions. Increasing the incubation temperature to 37°C
accelerated tissue autolysis. Therefore, our parameters for dextran
application to the cochlea are believed to provide the optimal results for
both signal intensity and tissue integrity. Cochleae were subsequently
perfused with 4% paraformaldehyde in 0.1 M phosphate buffer (pH 7.4) through
the round and oval windows and post-fixed overnight.
Immunocytochemistry
Immunocytochemistry enabled identification of type II SGN and cholinergic
efferent fibers using the antibodies against peripherin and choline
acetyltransferase (ChAT), respectively
(Sobkowicz and Emmerling,
1989
; Hafidi,
1998
). Peripherin is a 57 kDa type III intermediate filament
protein that in the rat cochlea is found only in type II SGN
(Hafidi, 1998
) and has been
used extensively as a specific marker for type II SGN
(Hafidi et al., 1993
;
Despres et al., 1994
;
Mou et al., 1998
;
Schimmang et al., 2003
).
Peripherin polyclonal rabbit antiserum (PII/SE411) against rat peptide
sequence IETRDGEKVVTESQKEQHSELDKSSIHSY was a gift from Dr Annie Wolff
(Djabali et al., 1991
;
Terao et al., 2000
). Choline
acetyltransferase (ChAT) polyclonal goat antibody (Chemicon) identified
cholinergic efferent fibers in the cochlea
(Sobkowicz and Emmerling,
1989
).
For whole-mount preparations, the spiral ligament, Reissners' membrane and tectorial membrane were removed to ensure antibody penetration. The apical, mid and basal regions of the cochlea were dissected separately to permit the study of spatial differences in innervation patterns. In addition, some cochleae were processed as floating sections. In these cases, cochleae were cryoprotected with 10% sucrose in 0.1 M PBS for 4 hours, then 30% sucrose in PBS overnight, followed by incubation in 30% sucrose and Tissue-Tek (OCT, Miles, IN) (1:1) for 1 hour. Cochleae were then mounted in OCT, frozen in dry ice and cryosectioned (CM1900 cryostat microtome, Leica, Germany) at 50 µm thickness into 0.1 M PBS.
Whole mounts or cross-sections were incubated in a blocking/permeabilizing
solution at 4°C for 1 hour [10% normal goat or horse serum (NGS or NHS;
Vector Laboratories, CA), and 1% Triton X-100 in 0.1 M PBS] and then incubated
at 4°C overnight in primary antibody solution: anti-peripherin antibody
(1:800 in 5% NGS in 0.1% Triton X-100 in 0.1 M PBS) for peripherin
immunolabeling; anti-ChAT antibody (1:200 in 5% NHS in 0.1% Triton X-100 in
0.1 M PBS) for ChAT immunolabeling. Alexa 488-conjugated goat anti-rabbit IgG
or Alexa 647-conjugated donkey anti-goat IgG (1:500; Molecular Probes), were
applied at room temperature (2 hours), then incubated at 4°C (2 hours).
After washes, the tissues were mounted on glass slides (Vectashield, Vector
Laboratories) and stored at 4°C. Omission of primary antibodies in
negative controls resulted in no signal (data not shown). The specificity of
peripherin expression in type II SGN was validated in previous studies
(Djabali et al., 1991
;
Hafidi et al., 1993
;
Despres and Romand, 1994
;
Mou et al., 1998
;
Terao et al., 2000
). We
further confirmed the specificity of our peripherin antibody by successfully
reproducing peripherin expression patterns in the neonatal rat cochlea as
described by Hafidi et al. (Hafidi et al.,
1993
) (see Fig. S2 in the supplementary material).
Image acquisition and analysis
Images were acquired via confocal microscopy (Leica TCS SP2, Germany, or
Olympus FV1000, Japan) and processed using Adobe Photoshop software. Maximal
intensity projections of stacks of optical sections were used to resolve
labeled nerve fibers within cochlear sections and whole mounts (Leica confocal
software or Olympus FV10-ASW 1.3). Three-dimensional reconstruction using
25 optical sections provided additional resolution of the afferent
innervation pattern (Image Pro Plus 3D suite, Media Cybernetics, MD, USA).
Unless otherwise stated, data presented here are from the mid-turn of the
cochlea. This enabled a comparison of innervation patterns across
developmental stages independent of the basal-to-apical cochlea maturation
gradient (Ruben, 1967
;
Lenoir et al., 1980
;
Roth and Bruns, 1992a
;
Roth and Bruns, 1992b
;
Pujol et al., 1998
).
| RESULTS |
|---|
|
|
|---|
|
|
Establishment of cochlear afferent innervation
Independent labeling of the type I and type II SGNs by TMRD and peripherin
enabled us to visualize and characterize the development of cochlear dual
afferent innervation patterns. As noted, presentation of data is primarily
from the mid-turn region of the cochlea to avoid the confounding complexity of
the base-apex maturation gradient (Ruben,
1967
; Lenoir et al.,
1980
; Pujol et al.,
1998
; Roth and Bruns,
1992a
; Roth and Bruns,
1992b
).
From E18 to P6, the neurite fiber tracts innervating the IHCs and OHCs
showed no overlapping labeling with TMRD and peripherin. At E18, TMRD labeling
of SGNs was evenly dispersed throughout all turns of the spiral ganglion
(Fig. 2A). Peripherin
immunolabeling was found in a subgroup of neurons throughout all turns, with
expression increasing in the mid and basal turn regions
(Fig. 2). In comparison to P6,
the peripherin-positive type II SGNs at E18 were more numerous and were not
restricted to the region close to the intraganglionic spiral bundle
(Fig. 1A,C,
Fig. 2A,
Fig. 3A,B). This is consistent
with reports of the peripherin expression of SGN in the developing rat cochlea
(Hafidi et al., 1993
). The mid
and basal turn regions of E18 cochlea showed an immature, unorganized
innervation of both IHCs and OHCs by TMRD- and peripherin-labeled neurite
populations (Fig. 3). Both
afferent fiber types projected to the IHC region and extended beyond this, as
neurites projecting to the OHC region (Fig.
3). The projecting neurites in the OHC region traveled short
distances and formed contacts with few, predominantly first row, OHCs
(Fig. 3B-D). The TMRD-labeled
type I neurites innervating the IHCs had extensive terminals on the lateral
walls of the cells (see Fig. S1 in the supplementary material), whereas the
peripherin-positive type II fibers innervating the IHC had short terminal
branches that were limited to the base of the cells. In the apical region at
E18, few neurites of either type reached the inner spiral plexus region; there
were no terminal processes on the IHCs and no fibers projecting to the OHCs
(not shown).
|
|
Afferent innervation at P3 represented the maximum overlap in neurite projections from type I and type II SGNs within the outer spiral bundles. Peripherin-expressing neurons were more frequently found within the outer region of the spiral ganglion (Figs 4, 5), adjacent to the intraganglionic spiral bundle of efferent fibers. Peripherin-expressing type II neurites no longer branched to innervate IHCs collaterally by P3 (Figs 4, 5). However, TMRD-labeled neurites still formed a calyceal-type innervation to the IHCs, but with a more limited basolateral association (Fig. 4D-F, Fig. 5A-C, Fig. 6G,H,J,K). Unlike the type I SGN innervation to the inner spiral plexus region beneath the IHCs, both TMRD- and peripherin-labeled neurites continued to project to all three rows of OHCs, with the structure of the outer spiral bundles becoming well defined (Fig. 4D-F, Fig. 5A-C, Fig. 6G,H,J,K). Three-dimensional reconstructions of confocal images were utilized to provide spatial resolution of the growth path of the neurites under the hair cell region (Fig. 5). At P3, there was a lack of peripherin labeling in the inner spiral plexus and IHC region. At the outer spiral bundles, TMRD-labeled type I neurites lay above the peripherin-positive type II fibers, showing that they utilized different growth paths (Fig. 5A-C, Fig. 6G,H,J,K). TMRD-labeled neurites traveled in fascicles directed towards the organ of Corti, but peripherin-labeled neurites traveled as single fibers in a more diagonal orientation and often crossed beneath bundles of type I neurites. Both type I and type II neurites frequently coursed between outer spiral bundle fiber tracts (see Movie S1 in the supplementary material).
|
| DISCUSSION |
|---|
|
|
|---|
Stages of development of the afferent innervation of the organ of Corti
The direct visualization of developing innervation patterns from embryonic
through postnatal development provided by this study has enabled the
identification of three distinct stages of cochlear afferent innervation: (1)
neurite growth and extension under the sensory hair cell region from both
types of SGN between E18 and P0; (2) neurite refinement under OHCs from both
types of SGN between P0 and P3; (3) neurite retraction of type I SGNs from
OHCs and synaptic pruning between P3 and P6.
|
Refinement of afferent fiber tracts and hair cell innervation (P0-P3)
The nerve fibers of both type I and type II SGNs are segregated into the
three defined outer spiral bundles beneath the rows of OHCs. During this
process, the type I SGN fiber tracts are separate, remaining dorsal to the
type II SGN fiber tracts (see Movie S1 in the supplementary material; P3 organ
of Corti innervation). In addition, type I SGN innervation of the IHCs was
refined, with calyceal terminal complexes forming around the basolateral
region of these cells. These data provide the first resolution of the
refinement of both the type I and type II afferent innervation to establish
the outer spiral bundles, and the localization of synaptic terminals around
the IHCs during this stage of afferent innervation. How fiber dominance is
established is not known, but our finding that TMRD can specifically label
type I fibers at this stage of development will enable future characterization
of exclusively type I fiber synaptogenesis and refinement onto the IHCs.
Neurite retraction and synaptic pruning (P3-P6)
The excess of nerve terminals and associated ribbon synapses present at the
OHCs is reduced to establish the mature innervation pattern
(Sobkowicz et al., 1982
;
Pujol et al., 1998
). This
suggests that the type I afferent nerve fibers form synaptic contacts with the
OHCs, which are then pruned, leading to withdrawal of this class of neurite
from the OHC region. TMRD-labeling of type I fibers enabled us to directly
visualize the type I fiber withdrawal from the OHCs (Figs
4,
5 and
6). By contrast, the
innervation pattern of the type II afferent nerve fibers is more stable and
could be seen to supplant the type I innervation between P3 and P6
(Fig. 5). As the retraction is
specific to type I fibers, this variation in type I versus type II stability
at the OHCs probably results from distinct differences in the properties of
the synaptic connections formed by the type I and type II fibers. The maturity
and the molecular makeup of the temporary type I synapses onto the OHCs is
currently unknown; however, glutamate receptors have been found to be
expressed by type I fibers at this stage of development
(Knipper et al., 1997
;
Eybalin et al., 2004
),
suggesting that these temporary synapses are at least capable of functional
neurotransmission with the OHCs. We hypothesize that it is the molecular
makeup of the temporary synapses that drives their retraction, with incomplete
type I synapse formation onto the OHCs, resulting in an inability to compete
against the stronger type II synapses. Direct competition for innervation is
well characterized at the neuromuscular junction
(Sanes and Lichtman, 2001
;
Lichtman and Sanes, 2003
;
Wyatt and Balice-Gordon, 2003
)
and may also occur in the inner ear. In addition, biochemical analysis has
revealed that excitatory synapses in other brain regions express a myriad of
proteins that play a pivotal role in targeting glutamate receptors to synapses
and anchoring them at the postsynaptic density
(Garner and Kindler, 1996
;
Montgomery et al., 2003
). The
differential expression of these postsynaptic density proteins at type I and
type II synapses could play a crucial role in determining whether a synapse is
temporary or stable and TMRD-labeling of type I fibers will enable future
molecular characterization of the synapses formed by these fibers.
Changes in hair cell function during neurite retraction and synapse pruning
may also contribute to variation in synaptic stability. For example, neonatal
hair cells exhibit spontaneous action potentials, but during the period of
neurite retraction this activity is lost as the membrane conductances mature
in the early postnatal period (Kros et
al., 1998
; Housley et al.,
2006
).
Our recent data also suggest that ATP-gated ionotropic P2X receptor
signaling contributes to neurite retraction
(Greenwood et al., 2007
). The
expression of the P2X3 subunits of ATP-gated ion channels in the
SGNs is developmentally regulated and is closely coordinated with the cochlear
afferent synaptic reorganization (Huang et
al., 2005
; Huang et al.,
2006
). P2X signaling was found to inhibit BDNF-induced neurite
outgrowth and branching (Greenwood et al.,
2007
), suggesting that during the maturation of cochlear
innervation, temporally regulated P2X receptor expression provides a potential
mechanism to control BDNF-stimulated outgrowth when neurite pruning is
required.
Development of type II fiber innervation
In the developing mouse cochlea, we found that peripherin was solely
expressed by the type II SGNs from E18 onwards. This is in contrast to the
developing rat cochlea, where peripherin is initially expressed in type I and
type II SGNs and then downregulated early in the first postnatal week
(Hafidi et al., 1993
). Our
data indicate that any expression of peripherin by type I SGNs would have to
occur before E18 in the mouse. Multiple previous studies have shown
anti-peripherin to exclusively stain type II neurons
(Hafidi et al., 1993
;
Despres et al., 1994
;
Mou et al., 1998
;
Schimmang et al., 2003
). We
verified that our identification of type II fibers in the mouse was specific
by replicating the peripherin labeling in the postnatal rat that was
previously described by Hafidi et al.
(Hafidi et al., 1993
) (see
Fig. S2 in the supplementary material). In our mouse tissue, 3D
reconstructions show that TMRD- and peripherin-labeled fiber tracts were
distinct within the osseous spiral lamina, outer spiral bundles and beneath
the IHCs (see Movies S1 and S2 in the supplementary material). The majority of
the peripherin-expressing neurites terminated on the OHCs during development,
but between E18 and P0 some peripherin-positive nerve fibers formed a
collateral innervation with the IHCs, supporting previous reports that type II
SGNs temporarily project to IHCs during cochlear development
(Perkins and Morest, 1975
).
Between E18 and P6, the number of peripherin-expressing neurons was decreased
and redistributed towards the intraganglionic spiral bundles. This may be the
result of cell migration and cell loss in the spiral ganglion during the first
postnatal week, which rearranges and reduces the SGN II cell soma density in
the ganglion, as has been evident in other species
(Echteler and Nofsinger, 2000
;
Ard and Morest, 1984
;
Rueda et al., 1987
). We also
observed that the peripherin-expressing type II SGNs in the mid and basal
turns were located mainly close to the lateral aspect of Rosenthal's canal,
where the intraganglionic spiral bundle region is located. The number of type
II SGNs gradually increased from the apical- to the mid-turn, consistent with
previous studies (Spoendlin,
1972
; Keithley and Feldman,
1979
; Hafidi et al.,
1993
). These data, together with the findings of previous studies
employing peripherin immunoreactivity
(Hafidi et al., 1993
;
Despres et al., 1994
;
Mou et al., 1998
;
Schimmang et al., 2003
),
verify the use of peripherin to label type II SGNs and therefore provide a
mechanism to independently identify the neurites of the type II SGN from the
TMRD-labeled type I neurites.
Efferent innervation
Efferent fiber innervation patterns were visualized with ChAT
immunolabeling (Sobkowicz and Emmerling,
1989
; Merchan Perez et al.,
1994
). ChAT labeling verified that the TMRD-positive fibers
examined during the neurite refinement and retraction stages were type I
fibers and not efferent fibers. In the mid-turn, we observed no ChAT
immunolabeling under the IHCs or OHCs until P3. By P6, some ChAT-positive
efferent tunnel-crossing fibers were matched with limited TMRD labeling.
ChAT-positive efferent fiber labeling in the region of the inner spiral plexus
at P3 and P6 was lateral and basal to the TMRD-labeled SGN innervation of the
hair cells. In addition to ChAT labeling, at P6 the efferent fibers could
easily be distinguished by their unique travel path crossing the tunnel of
Corti. TMRD-labeling of the efferent fibers in the mid-turn of the cochlea was
not significant until P6, by which time the refinement and retraction of
TMRD-labeled type I fibers was largely complete.
Our observed ChAT labeling is identical to that reported by Sobkowicz and
Emmerling, (Sobkowicz and Emmerling,
1989
), consistent with increased postnatal ChAT expression
correlating with efferent synaptogenesis
(Sobkowicz and Emmerling,
1989
; Merchan Perez et al.,
1994
). Studies using DiI to characterize the development of
efferent innervation (Fritzsch and
Nichols, 1993
; Bruce et al.,
1997
) show an earlier arrival of efferent nerve fibers in the
organ of Corti: in the basal turn, DiI-labeled efferents could be seen
extending to the OHCs by birth, lagging only slightly behind afferent
innervation at the same stage (Bruce et
al., 1997
). Our observed absence of ChAT labeling in the mid-turn
before P3 could be due to a lack of ChAT expression until after efferent nerve
terminals are formed between P2 and P7
(Shnerson et al., 1982
).
However, examination of ChAT labeling in the basal turn revealed efferent
fibers extending towards the inner hair cells at P0 (not shown), consistent
with the timecourse from studies utilizing DiI labeling of efferents
(Bruce et al., 1997
) and with
ChAT expression under the IHCs at the basal turn at P0
(Sobkowicz and Emmerling,
1989
). Therefore, we believe that the lack of ChAT labeling we
observed at P0 in the mid-turn is due to the basal-apical gradient, which can
result in a lag in innervation of as much as 4 days. Our ChAT labeling
provides an accurate picture of efferent innervation patterns and confirmed
that up to P6, when the afferent neural innervation of the cochlea approached
the mature configuration, TMRD labeling was able to specifically resolve the
type I SGN innervation.
TMRD labeling of type I SGN
The TMRD-specific labeling of type I fibers has enabled for the first time
the characterization of the developmental innervation patterns of type I and
type II afferent fibers independently. The mechanism that allows TMRD to
selectively label type I nerve fibers probably relates to the diameter of the
nerve fibers that were sectioned to provide the dextran uptake pathway. The
diameters of both type I SGNs (>1 µm) and cholinergic efferent fibers
(
0.8 µm) are larger than for type II SGNs (<0.7 µm) in the adult
mouse (Brown and Ledwith, 3rd,
1990
; Wilson et al.,
1991
). We hypothesize that the smaller-diameter type II nerve
fibers reseal before the dextran crystals can be taken up by these fibers.
Additional potential mechanisms that underlie TMRD-specific labeling of type I
fibers include a lower dextran diffusion efficiency in type II versus type I
fibers due to a high density cytoskeletal meshwork in type II fibers
(Schwartz et al., 1983
;
Dau and Wenthold, 1989
). In
addition, a higher dextran transport efficiency in the anterograde direction
(Fritzsch, 1993
;
Kobbert et al., 2000
) may have
enabled TMRD labeling of efferent nerve fibers in the later stage of cochlear
neural development.
Conclusions
Our data have defined the spatial and temporal development of cochlear
afferent innervation by type I and type II SGN populations. We have identified
three stages of the afferent innervation between E18 and P6: (1) neurite
growth and extension of both classes of afferents to all the hair cells; (2)
neurite refinement, with formation of the outer spiral bundles under OHCs; (3)
neurite retraction and synaptic pruning to eliminate type I innervation of
OHCs, while retaining their innervation of IHCs. These developmental stages
are required to establish the mature cochlea innervation pattern. This precise
spatiotemporal regulation of afferent nerve fiber development in the cochlea
is probably to be associated with specific differences in the properties of
the synapses formed by type I and II SGNs. The study also highlights the
cochlea as a powerful model system for the study of synapse development,
elimination and neurite retraction in the developing central nervous
system.
Supplementary material
Supplementary material for this article is available at
http://dev.biologists.org/cgi/content/full/134/16/2925/DC1
| ACKNOWLEDGMENTS |
|---|
| Footnotes |
|---|
| REFERENCES |
|---|
|
|
|---|
Ard, M. D. and Morest, D. K. (1984). Cell death during development of the cochlear and vestibular ganglia of the chick. Int. J. Dev. Neurosci. 2, 535-547.[CrossRef]
Boyer, S., Ruel, J., Puel, J. L. and Chabbert, C. (2004). A procedure to label inner ear afferent nerve endings for calcium imaging. Brain Res. Brain Res. Protoc. 13, 91-98.[CrossRef][Medline]
Brown, M. C. and Ledwith, J. V., 3rd (1990). Projections of thin (type-II) and thick (type-I) auditory-nerve fibers into the cochlear nucleus of the mouse. Hear. Res. 49,105 -118.[CrossRef][Medline]
Bruce, L. L., Kingsley, J., Nichols, D. H. and Fritzsch, B. (1997). The development of vestibulocochlear efferents and cochlear afferents in mice. Int. J. Dev. Neurosci. 15,671 -692.[CrossRef][Medline]
Burda, H. and Branis, M. (1988). Postnatal development of the organ of Corti in the wild house mouse, laboratory mouse, and their hybrid. Hear. Res. 36, 97-105.[CrossRef][Medline]
Coppola, V., Kucera, J., Palko, M. E., Martinez-De Velasco, J.,
Lyons, W. E., Fritzsch, B. and Tessarollo, L. (2001).
Dissection of NT3 functions in vivo by gene replacement strategy.
Development 128,4315
-4327.
Darrow, K. N., Maison, S. F. and Liberman, M. C. (2006). Cochlear efferent feedback balances interaural sensitivity. Nat. Neurosci. 9,1474 -1476.[CrossRef][Medline]
Darrow, K. N., Maison, S. F. and Liberman, M. C.
(2007). Selective removal of lateral olivocochlear efferents
increases vulnerability to acute acoustic injury. J.
Neurophysiol. 97,1775
-1785.
Dau, J. and Wenthold, R. J. (1989). Immunocytochemical localization of neurofilament subunits in the spiral ganglion of normal and neomycin-treated guinea pigs. Hear. Res. 42,253 -263.[CrossRef][Medline]
Despres, G., Leger, G. P., Dahl, D. and Romand, R. (1994). Distribution of cytoskeletal proteins (neurofilaments, peripherin and MAP-tau) in the cochlea of the human fetus. Acta Otolaryngol. 114,377 -381.[Medline]
Djabali, K., Portier, M. M., Gros, F., Blobel, G. and Georgatos, S. D. (1991). Network antibodies identify nuclear lamin B as a physiological attachment site for peripherin intermediate filaments. Cell 64,109 -121.[CrossRef][Medline]
Echteler, S. M. (1992). Developmental
segregation in the afferent projections to mammalian auditory hair cells.
Proc. Natl. Acad. Sci. USA
89,6324
-6327.
Echteler, S. M. and Nofsinger, Y. C. (2000). Development of ganglion cell topography in the postnatal cochlea. J. Comp. Neurol. 425,436 -446.[CrossRef][Medline]
Eybalin, M., Caicedo, A., Renard, N., Ruel, J. and Puel, J. L. (2004). Transient Ca2+-permeable AMPA receptors in postnatal rat primary auditory neurons. Eur. J. Neurosci. 20,2981 -2989.[CrossRef][Medline]
Farinas, I., Jones, K. R., Tessarollo, L., Vigers, A. J., Huang,
E., Kirstein, M., de Caprona, D. C., Coppola, V., Backus, C., Reichardt, L. F.
et al. (2001). Spatial shaping of cochlear innervation by
temporally regulated neurotrophin expression. J.
Neurosci. 21,6170
-6180.
Fritzsch, B. (1993). Fast axonal diffusion of 3000 molecular weight dextran amines. J. Neurosci. Methods 50,95 -103.[CrossRef][Medline]
Fritzsch, B. and Nichols, D. H. (1993). DiI reveals a prenatal arrival of efferents at the differentiating otocyst of mice. Hear. Res. 65,51 -60.[CrossRef][Medline]
Fritzsch, B., Pauley, S., Matei, V., Katz, D. M., Xiang, M. and Tessarollo, L. (2005). Mutant mice reveal the molecular and cellular basis for specific sensory connections to inner ear epithelia and primary nuclei of the brain. Hear. Res. 206, 52-63.[CrossRef][Medline]
Garner, C. C. and Kindler, S. (1996). Synaptic proteins and the assembly of synaptic junctions. Trends Cell Biol. 6,429 -433.[CrossRef][Medline]
Gimlich, R. L. and Braun, J. (1985). Improved fluorescent compounds for tracing cell lineage. Dev. Biol. 109,509 -514.[CrossRef][Medline]
Glover, J. C., Petursdottir, G. and Jansen, J. K. (1986). Fluorescent dextranamines used as axonal tracers in the nervous system of the chicken embryo. J. Neurosci. Methods 18,243 -254.[CrossRef][Medline]
Greenwood, D., Jagger, D. J., Huang, L.-C., Hoya, N., Thorne, P.
R., Wildman, S. S., King, B. F., Pak, K., Ryan, A. F. and Housley, G. D.
(2007). P2X receptor signaling inhibits BDNF-mediated spiral
ganglion neuron development in the neonatal rat cochlea.
Development 134,1407
-1417.
Gu, C., Rodriguez, E. R., Reimert, D. V., Shu, T., Fritzsch, B., Richards, L. J., Kolodkin, A. L. and Ginty, D. D. (2003). Neurophilin-1 conveys semaphorin and VEGF signaling during neural and cardiovascular development. Dev. Cell 5, 45-57.[CrossRef][Medline]
Hafidi, A. (1998). Peripherin-like immunoreactivity in type II spiral ganglion cell body and projections. Brain Res. 805,181 -190.[CrossRef][Medline]
Hafidi, A., Despres, G. and Romand, R. (1993). Ontogenesis of type II spiral ganglion neurons during development: peripherin immunohistochemistry. Int. J. Dev. Neurosci. 11,507 -512.[CrossRef][Medline]
Housley, G. D., Marcotti, W., Navaratnam, D. and Yamoah, E. N. (2006). Hair cells-beyond the transducer. J. Membr. Biol. 209,89 -118.[CrossRef][Medline]
Huang, E. J., Liu, W., Fritzsch, B., Bianchi, L. M., Reichardt,
L. F. and Xiang, M. (2001). Brn3a is a transcriptional
regulator of soma size, target field innervation and axon path finding of
inner ear sensory neurons. Development
128,2421
-2432.
Huang, L. C., Greenwood, D., Thorne, P. R. and Housley, G. D. (2005). Developmental regulation of neuron-specific P2X3 receptor expression in the rat cochlea. J. Comp. Neurol. 484,133 -143.[CrossRef][Medline]
Huang, L. C., Ryan, A. F., Cockayne, D. A. and Housley, G. D. (2006). Developmentally regulated expression of the P2X(3) receptor in the mouse cochlea. Histochem. Cell Biol. 125,681 -692.[CrossRef][Medline]
Jagger, D. J. and Housley, G. D. (2003).
Membrane properties of type II spiral ganglion neurones identified in a
neonatal rat cochlear slice. J. Physiol.
552,525
-533.
Kaneko, T., Saeki, K., Lee, T. and Mizuno, N. (1996). Improved retrograde axonal transport and subsequent visualization of tetramethylrhodamine (TMR) -dextran amine by means of an acidic injection vehicle and antibodies against TMR. J. Neurosci. Methods 65,157 -165.[CrossRef][Medline]
Keithley, E. M. and Feldman, M. L. (1979). Spiral ganglion cell counts in an age-graded series of rat cochleas. J. Comp. Neurol. 188,429 -442.[CrossRef][Medline]
Keithley, E. M. and Feldman, M. L. (1982). Hair cell counts in an age-graded series of rat cochleas. Hear. Res. 8,249 -262.[CrossRef][Medline]
Knipper, M., Kopschall, I., Rohbock, K., Kopke, A. K., Bonk, I., Zimmermann, U. and Zenner, H. (1997). Transient expression of NMDA receptors during rearrangement of AMPA-receptor-expressing fibers in the developing inner ear. Cell Tissue Res. 287, 23-41.[CrossRef][Medline]
Kobbert, C., Apps, R., Bechmann, I., Lanciego, J. L., Mey, J. and Thanos, S. (2000). Current concepts in neuroanatomical tracing. Prog. Neurobiol. 62,327 -351.[CrossRef][Medline]
Kros, C. J., Ruppersberg, J. P. and Rusch, A. (1998). Expression of a potassium current in inner hair cells during development of hearing in mice. Nature 394,281 -284.[CrossRef][Medline]
Lenoir, M., Shnerson, A. and Pujol, R. (1980). Cochlear receptor development in the rat with emphasis on synaptogenesis. Anat. Embryol. 160,253 -262.[CrossRef][Medline]
Lichtman, J. W. and Sanes, J. R. (2003). Watching the neuromuscular junction. J. Neurocytol. 32,767 -775.[CrossRef][Medline]
Malenka, R. C. (2003). The long-term potential of LTP. Nat. Neurosci. Rev. 4, 923-926.[CrossRef]
Merchan Perez, A., Gil-Loyzaga, P., Eybalin, M., Fernandez Mateos, P. and Bartolome, M. V. (1994). Choline-acetyltransferase-like immunoreactivity in the organ of Corti of the rat during postnatal development. Brain Res. Dev. Brain Res. 82,29 -34.[CrossRef][Medline]
Montgomery, J. M. and Madison, D. V. (2004). Discrete synaptic states define a major mechanism for synaptic plasticity. Trends Neurosci. 27,744 -750.[CrossRef][Medline]
Montgomery, J. M., Zamorano, P. and Garner, C. C. (2003). MAGUKs in synapse assembly and function: an emerging view. Cell. Mol. Life Sci. 61,911 -929.
Mou, K., Adamson, C. L. and Davis, R. L. (1998). Time-dependence and cell-type specificity of synergistic neurotrophin actions on spiral ganglion neurons. J. Comp. Neurol. 402,129 -139.[CrossRef][Medline]
Oster, S. F. and Sretavan, D. W. (2003).
Connecting the eye to the brain: the molecular basis of ganglion cell axon
guidance. Br. J. Ophthalmol.
87,639
-645.
Perkins, R. E. and Morest, D. K. (1975). A study of cochlear innervation patterns in cats and rats with the Golgi method and Nomarkski Optics. J. Comp. Neurol. 163,129 -158.[CrossRef][Medline]
Pickles, J. (1988). An Introduction to the Physiology of Hearing. London: Academic Press.
Pirvola, U., Ylikoski, J., Palgi, J., Lehtonen, E., Arumae, U.
and Saarma, M. (1992). Brain-derived neurotrophic factor and
neurotrophin 3 mRNAs in the peripheral target fields of developing inner ear
ganglia. Proc. Natl. Acad. Sci. USA
89,9915
-9919.
Popov, S. and Poo, M. M. (1992). Diffusional transport of macromolecules in developing nerve processes. J. Neurosci. 12,77 -85.[Abstract]
Pujol, R., Lavigne-Rebillard, M. and Lenoir, M. (1998). Development of sensory and neural structures in the mammalian cochlea. In Development of the Auditory System (ed. E. W. Rubel, A. N. Popper and R. R. Fay), pp.146 -192. New York: Springer.
Roth, B. and Bruns, V. (1992a). Postnatal development of the rat organ of Corti. I. General morphology, basilar membrane, tectorial membrane and border cells. Anat. Embryol. 185,559 -569.[Medline]
Roth, B. and Bruns, V. (1992b). Postnatal development of the rat organ of Corti. II. Hair cell receptors and their supporting elements. Anat. Embryol. 185,571 -581.[Medline]
Rubel, E. W. and Fritzsch, B. (2002). Auditory system development: primary auditory neurons and their targets. Annu. Rev. Neurosci. 25,51 -101.[Medline]
Ruben, R. J. (1967). Development of the inner ear of the mouse: a radioautographic study of terminal mitoses. Acta Otolaryngol. Suppl. 220, 1-44.
Rueda, J., de la Sen, C., Juiz, J. M. and Merchan, J. A. (1987). Neuronal loss in the spiral ganglion of young rats. Acta Otolaryngol. 104,417 -421.[Medline]
Sanes, J. R. and Lichtman, J. W. (2001). Induction, assembly, maturation and maintenance of a postsynaptic apparatus. Nat. Rev. Neurosci. 2,791 -805.[Medline]
Schimmang, T., Tan, J., Muller, M., Zimmermann, U., Rohbock, K.,
Kopschall, I., Limberger, A., Minichiello, L. and Knipper, M.
(2003). Lack of Bdnf and TrkB signalling in the postnatal cochlea
leads to a spatial reshaping of innervation along the tonotopic axis and
hearing loss. Development
130,4741
-4750.
Schwartz, A. M., Parakkal, M. and Gulley, R. L. (1983). Postnatal development of spiral ganglion cells in the rat. Am. J. Anat. 167,33 -41.[CrossRef][Medline]
Shnerson, A., Devigne, C. and Pujol, R. (1982). Age-related changes in the C57BL/6J mouse cochlea. II. Ultrastructural findings. Dev. Brain Res. 2, 77-88.
Simmons, D. D. (1994). A transient afferent innervation of outer hair cells in the postnatal cochlea. NeuroReport 5,1309 -1312.[Medline]
Slepecky, N. B. (1996). Structure of the mammalian cochlea. In The Cochlea (ed. P. Dallos, A. N. Popper and R. R. Fay), pp. 44-129. New York: Springer.
Sobkowicz, H. M. and Emmerling, M. R. (1989). Development of acetylcholinesterase-positive neuronal pathways in the cochlea of the mouse. J. Neurocytol. 18,209 -224.[CrossRef][Medline]
Sobkowicz, H. M., Rose, J. E., Scott, G. E. and Slapnick, S. M. (1982). Ribbon synapses in the developing intact and cultured organ of Corti in the mouse. J. Neurosci. 2, 942-957.[Abstract]
Sobkowicz, H. M., Slapnick, S. M. and August, B. K. (2003). Reciprocal synapses between inner hair cell spines and afferent dendrites in the organ of corti of the mouse. Synapse 50,53 -66.[CrossRef][Medline]